Global Small-Molecule APIs Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q3 2018 Update)
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Stakeholders
2. Research & Forecasting
- 2.1. Research Methodology
- 2.1.1. Research Instruments
- 2.1.1.1. Secondary Instrument
- 2.1.1.2. Primary Instrument
- 2.1.2. Research Approaches
- 2.1.2.1. Bottom-up Approach
- 2.1.2.2. Top-down Approach
- 2.1.3. Research Reliability & Validity
- 2.1.4. Research Assumptions
- 2.1.5. Vendor Inclusion Criteria
- 2.1.1. Research Instruments
- 2.2. Forecasting Methodology
- 2.2.1. Methodology for Market Estimation & Forecasting
- 2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
4. Premium Insight
- 4.1. Market Connectivity
- 4.2. Market Data Feed
- 4.3. Market Vendor Ranking Analysis
- 4.4. Market Dynamics
- 4.4.1. Drivers
- 4.4.2. Restraints
- 4.4.3. Opportunities
- 4.4.4. Challenges
- 4.5. Porter’s Five Forces Analysis
- 4.5.1. Threat of New Entrants
- 4.5.2. Threat of Substitutes
- 4.5.3. Bargaining Power of Customers
- 4.5.4. Bargaining Power of Suppliers
- 4.5.5. Industry Rivalry
5. Global Small-Molecule APIs Market, by Production
- 5.1. Introduction
- 5.2. Contract Manufacturing
- 5.3. In-house Manufacturing
6. Global Small-Molecule APIs Market, by Type
- 6.1. Introduction
- 6.2. Biological
- 6.3. Synthetic
7. Global Small-Molecule APIs Market, by Application
- 7.1. Introduction
- 7.2. Cardiovascular
- 7.3. Diabetes
- 7.4. Immunological Disorders
- 7.5. Oncology
8. Global Small-Molecule APIs Market, by Geography
- 8.1. Introduction
- 8.2. Americas Small-Molecule APIs Market
- 8.2.1. Americas Small-Molecule APIs Market, by Country
- 8.2.1.1. United States
- 8.2.1.2. Brazil
- 8.2.1.3. Canada
- 8.2.1.4. Mexico
- 8.2.1.5. Argentina
- 8.2.2. Americas Small-Molecule APIs Market, by Production
- 8.2.3. Americas Small-Molecule APIs Market, by Type
- 8.2.4. Americas Small-Molecule APIs Market, by Application
- 8.2.1. Americas Small-Molecule APIs Market, by Country
- 8.3. Europe, Middle East & Africa Small-Molecule APIs Market
- 8.3.1. Europe, Middle East & Africa Small-Molecule APIs Market, by Country
- 8.3.1.1. United Kingdom
- 8.3.1.2. Germany
- 8.3.1.3. France
- 8.3.1.4. Saudi Arabia
- 8.3.1.5. United Arab Emirates
- 8.3.1.6. Italy
- 8.3.1.7. Russia
- 8.3.2. Europe, Middle East & Africa Small-Molecule APIs Market, by Production
- 8.3.3. Europe, Middle East & Africa Small-Molecule APIs Market, by Type
- 8.3.4. Europe, Middle East & Africa Small-Molecule APIs Market, by Application
- 8.3.1. Europe, Middle East & Africa Small-Molecule APIs Market, by Country
- 8.4. Asia-Pacific Small-Molecule APIs Market
- 8.4.1. Asia-Pacific Small-Molecule APIs Market, by Country
- 8.4.1.1. China
- 8.4.1.2. Japan
- 8.4.1.3. India
- 8.4.1.4. Australia
- 8.4.2. Asia-Pacific Small-Molecule APIs Market, by Production
- 8.4.3. Asia-Pacific Small-Molecule APIs Market, by Type
- 8.4.4. Asia-Pacific Small-Molecule APIs Market, by Application
- 8.4.1. Asia-Pacific Small-Molecule APIs Market, by Country
9. Competitive Strategic Window
- 9.1. Introduction
- 9.1.1. Leverage Zone
- 9.1.2. Vantage Zone
- 9.1.3. Speculative Zone
- 9.1.4. Bottleneck Zone
10. FPNV Positioning Matrix
- 10.1. Introduction
- 10.2. Scores
- 10.2.1. Forefront
- 10.2.2. Pathfinders
- 10.2.3. Niche
- 10.2.4. Vital
- 10.3. Business Strategy
- 10.4. Product Satisfaction
11. Competitive News Feed Analysis
12. Company Usability Profiles
- 12.1. Albany Molecular Research Inc.
- 12.2. AstraZeneca PLC
- 12.3. BASF SE
- 12.4. Bachem Holding AG
- 12.5. Boehringer Ingelheim GmbH
- 12.6. Bristol-Myers Squibb
- 12.7. Cambrex Corporation
- 12.8. DSM
- 12.9. F. Hoffmann-La Roche Ltd,
- 12.10. GILEAD Science Inc.
- 12.11. GlaxoSmithKline PLC
- 12.12. Johnson & Johnson Inc.
- 12.13. Johnson Matthey Plc
- 12.14. Merck & Co, Inc.
- 12.15. Novartis AG
- 12.16. PCAS SA
- 12.17. Pfizer, Sanofi S.A.
- 12.18. Siegfried Holding AG
- 12.19. Teva Pharmaceutical Industries Limited
13. Appendix
- 13.1. Top Reports
- 13.2. Author Details
LIST OF TABLES (32 TABLES)
TABLE 1. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 2. GLOBAL SMALL-MOLECULE APIS MARKET RANKING, BY VENDORS, 2017
TABLE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2016 - 2024 (USD MILLION)
TABLE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 6. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 13. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 14. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 15. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 16. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2016 - 2024 (USD MILLION)
TABLE 17. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 18. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2016 - 2024 (USD MILLION)
TABLE 21. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 22. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 23. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 24. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2016 - 2024 (USD MILLION)
TABLE 25. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 26. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 27. 360IRESEARCH SCORES FOR FOREFRONT IN SMALL-MOLECULE APIS MARKET
TABLE 28. 360IRESEARCH SCORES FOR PATHFINDERS IN SMALL-MOLECULE APIS MARKET
TABLE 29. 360IRESEARCH SCORES FOR NICHE IN SMALL-MOLECULE APIS MARKET
TABLE 30. 360IRESEARCH SCORES FOR VITAL IN SMALL-MOLECULE APIS MARKET
TABLE 31. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR SMALL-MOLECULE APIS MARKET
TABLE 32. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR SMALL-MOLECULE APIS MARKET
LIST OF FIGURES (28 TABLES)
FIGURE 1. GLOBAL SMALL-MOLECULE APIS MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL SMALL-MOLECULE APIS MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL SMALL-MOLECULE APIS MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL SMALL-MOLECULE APIS MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL SMALL-MOLECULE APIS MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL SMALL-MOLECULE APIS MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL SMALL-MOLECULE APIS MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL SMALL-MOLECULE APIS MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL SMALL-MOLECULE APIS MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. SMALL-MOLECULE APIS MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2016 - 2024 (USD MILLION)
FIGURE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2017 VS 2024 (USD MILLION)
FIGURE 13. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 14. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 15. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2017 VS 2024 (USD MILLION)
FIGURE 16. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 17. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 18. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2017 VS 2024 (USD MILLION)
FIGURE 19. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 20. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 21. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 22. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 23. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 24. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SMALL-MOLECULE APIS MARKET, BY PRODUCTION, 2024
FIGURE 25. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SMALL-MOLECULE APIS MARKET, BY TYPE, 2024
FIGURE 26. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SMALL-MOLECULE APIS MARKET, BY APPLICATION, 2024
FIGURE 27. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SMALL-MOLECULE APIS MARKET, BY GEOGRAPHY, 2024
FIGURE 28. 360IRESEARCH FPNV POSITIONING MATRIX FOR SMALL-MOLECULE APIS MARKET
The global small-molecule apis market is expected to grow from USD 120,654.35 million 2017 to USD 178,852.47 million by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 5.78%.
On the basis of production, the global small-molecule apis market is studied across Contract Manufacturing and In-house Manufacturing.
On the basis of type, the global small-molecule apis market is studied across Biological and Synthetic.
On the basis of application, the global small-molecule apis market is studied across Cardiovascular, Diabetes, Immunological Disorders, and Oncology.
On the basis of geography, the global small-molecule apis market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).
“Albany Molecular Research Inc.: The potential growing player for the global small-molecule apis market”
The key players profiled in the global small-molecule apis market are Albany Molecular Research Inc., AstraZeneca PLC, BASF SE, Bachem Holding AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Cambrex Corporation, DSM, F. Hoffmann-La Roche Ltd,, GILEAD Science Inc., GlaxoSmithKline PLC, Johnson & Johnson Inc., Johnson Matthey Plc, Merck & Co, Inc., Novartis AG, PCAS SA, Pfizer, Sanofi S.A., Siegfried Holding AG, and Teva Pharmaceutical Industries Limited.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global small-molecule apis market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global small-molecule apis market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global small-molecule apis market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global small-molecule apis market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global small-molecule apis market.